| Product Code: ETC9971386 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neuromodulation Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neuromodulation Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neuromodulation Market - Industry Life Cycle |
3.4 United States (US) Neuromodulation Market - Porter's Five Forces |
3.5 United States (US) Neuromodulation Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United States (US) Neuromodulation Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F |
3.7 United States (US) Neuromodulation Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Neuromodulation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders and chronic pain conditions in the US. |
4.2.2 Technological advancements and innovations in neuromodulation devices. |
4.2.3 Growing acceptance and adoption of neuromodulation therapies among patients and healthcare providers. |
4.3 Market Restraints |
4.3.1 High cost associated with neuromodulation treatments. |
4.3.2 Stringent regulatory requirements for approval of neuromodulation devices. |
4.3.3 Limited reimbursement policies for neuromodulation procedures. |
5 United States (US) Neuromodulation Market Trends |
6 United States (US) Neuromodulation Market, By Types |
6.1 United States (US) Neuromodulation Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neuromodulation Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United States (US) Neuromodulation Market Revenues & Volume, By Internal Neuromodulation, 2021- 2031F |
6.1.4 United States (US) Neuromodulation Market Revenues & Volume, By External Neuromodulation, 2021- 2031F |
6.2 United States (US) Neuromodulation Market, By Biomaterial |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neuromodulation Market Revenues & Volume, By Metallic Biomaterials, 2021- 2031F |
6.2.3 United States (US) Neuromodulation Market Revenues & Volume, By Polymeric Biomaterials, 2021- 2031F |
6.2.4 United States (US) Neuromodulation Market Revenues & Volume, By Ceramic Biomaterials, 2021- 2031F |
6.3 United States (US) Neuromodulation Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neuromodulation Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.3.3 United States (US) Neuromodulation Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.4 United States (US) Neuromodulation Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.5 United States (US) Neuromodulation Market Revenues & Volume, By Dystonia, 2021- 2031F |
6.3.6 United States (US) Neuromodulation Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.3.7 United States (US) Neuromodulation Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Neuromodulation Market Import-Export Trade Statistics |
7.1 United States (US) Neuromodulation Market Export to Major Countries |
7.2 United States (US) Neuromodulation Market Imports from Major Countries |
8 United States (US) Neuromodulation Market Key Performance Indicators |
8.1 Patient satisfaction rates with neuromodulation therapies. |
8.2 Number of FDA approvals for new neuromodulation devices. |
8.3 Adoption rates of neuromodulation treatments by healthcare facilities. |
8.4 Average waiting time for neuromodulation procedures. |
8.5 Number of clinical trials and research studies conducted on neuromodulation therapies. |
9 United States (US) Neuromodulation Market - Opportunity Assessment |
9.1 United States (US) Neuromodulation Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United States (US) Neuromodulation Market Opportunity Assessment, By Biomaterial, 2021 & 2031F |
9.3 United States (US) Neuromodulation Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Neuromodulation Market - Competitive Landscape |
10.1 United States (US) Neuromodulation Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neuromodulation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here